SOLICITATION NOTICE
A -- Research and Development
- Notice Date
- 2/17/2004
- Notice Type
- Solicitation Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive, Suite 2NE70, MSC 4811, Bethesda, MD, 20817
- ZIP Code
- 20817
- Solicitation Number
- NOI4049
- Response Due
- 2/27/2004
- Archive Date
- 3/13/2004
- Point of Contact
- William Rosa, Purchasing Agent, Phone 301-402-6655, Fax 301-480-3695, - Crystal Brown, Contracting Officer, Phone 301-402-6545, Fax 301-480-3695,
- E-Mail Address
-
wrosa@niaid.nih.gov, cbrown@niaid.nih.gov
- Description
- The National Institutes of Health (NIH), National Institute of Allergies and Infectious Diseases (NIAID) intends to negotiate on a sole source basis, with Ani Lytics, Inc for the analysis of clinical tests from on-going clinical trials. This Notice Of Intent is being issued as NOI4049. The statutory authority for this acquisition is FAR 13.501 and award is anticipated to be made under a Firm Fixed Price purchase order. The acquisition documents and incorporated provisions and classes are those in effect in the Federal Acquisition Circular 2001-18 dated December 11, 2003. This acquisition will be processed under the authority of FAR Part 12-- Acquisition of Commercial Items. The North American Industry Classification Systems (NAICS) code for this acquisition is 541380 and the business size standard is $6 million. The period of performance of this contract will be from March 1, 2004 through February 28, 2005. NIAID studies the etiology, pathogenesis and prevention of viral hepatitis and other diseases. Current research efforts include elucidation of the molecular virology of hepatitis A and the development of a live-attenuated hepatitis A vaccine, delineation of the genetic heterogeneity of hepatitis C virus and characterization of the immune response to it, the diagnosis and prevention of hepatitis E, and the molecular and biological characterization of newly discovered hepatitis C-like viruses of humans and primates. These activities require the inoculation of animals, principally nonhuman primates, with clinical materials and the study of the resulting response of the animals. This requires testing animals for physiological, immunological and biochemical changes over time. A critical part of this analysis is testing serum liver enzyme levels, bilirubin levels, other clinical chemistry values and hematologic changes. The tests to be performed are Isocitrate Dehydrogenase (ICD), Amino Aline Transferase (ALT) and Gamma Glutamine Tranferase. These tests are non-routine analyses established exclusively at Ani Lytics, Inc. expressly for this study. Since Ani Lytics has extensively performed this test for NIAID in the past they must continue to provide the testing in order to compare data analyses and maintain consistency in the results. The necessary services are commercial as defined in FAR Part 2. This action is under the authority of 41 U.S.C. 253(c) (1), as set forth in FAR 6.302-1 and HHSAR 306-302-1. Only one responsible source and no other supplies or services will satisfy agency requirements. Interested parties may identify their interest and capability to respond to the requirement or submit proposals. This is not a request for competitive quotations. However, if any interested party believes it can perform the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other furnished information must be in writing and must contain material in sufficient detail to allow NIAID to determine if the party can perform this requirement. Capability statements must be received in the contracting office by 4:00 PM EST, February 27, 2004. If you have any questions they must be submitted in writing to William Rosa, Purchasing Agent, at wrosa@mail.nih.gov or by fax 301-480-3695. For delivery through the postal service the address is NIH/NIAID/AMOB, 10401 Fernwood Drive, Suite 2NE70, Room/2NE70C, MSC/4811, Bethesda, Maryland 20817-4812. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Solicitation number must be cited on all correspondence, NOI-4049.
- Web Link
-
Link to FedBizOpps document.
(http://www.eps.gov/spg/HHS/NIH/AMOB/NOI4049/listing.html)
- Place of Performance
- Address: National Institutes of Health, Bethesda, Maryland
- Zip Code: 20892
- Country: USA
- Zip Code: 20892
- Record
- SN00523119-F 20040219/040217221847 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |